What changed
Google made AlphaFold 3 generally available through its agent platform for allowlisted commercial research, supporting structure and interaction predictions across proteins, DNA, RNA, ligands, and ions.
Why it matters
A major biological prediction model gained a supported commercial access path with custom-ligand and pipeline options beyond its non-commercial academic distribution.
What to do
Request access only for a defined research workflow, benchmark held-out known complexes, track confidence and failure modes, budget concurrency, and retain laboratory validation.
Caveat
Access required approval and a commercial subscription, concurrency was limited per node, and structural predictions are not clinical advice, experimental proof, or guaranteed binding evidence.